Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Oni BioPharma has appointed David Hirsch as its new COO and CFO to succeed Dorothy Delfino, who is retiring from the company.
Subscribe to our email newsletter
Mr Hirsch began working for the company as a consultant in April 2008 and joined the company as a full-time employee in May 2008. Ms Delfino will remain with the company on a consultant basis.
Prior to joining Oni BioPharma, Mr Hirsch operated a boutique legal and consulting practice with a focus on financing and advising emerging technology companies.
Mr Hirsch holds a MSIA (MBA) from the Tepper School of Business at Carnegie Mellon University, a JD from Drake University Law School and a BA in economics from Indiana University.
Stanley Stein, president and CEO of Oni BioPharma, said: “We are certainly excited about having David join us. His breadth of experience in marketing, operations and finance will be very valuable to Oni BioPharma.”